Business
Data is Becoming Cannabis’ Most Valuable Crop
For more than a decade now, the world’s largest retail conglomerates have been quietly building their consumer data empires.
canada
265stories
13 Auglast updated
More in canada
- Interviews
From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light
Last year (fiscal year 2024/2025), Canada’s legal cannabis industry recorded revenues of CA$5.5bn, according to the latest figures from Statistics Canada.
- Interviews
‘Thoughtful, Prudent, Patient’ – Why Village Farms Is Sitting Out the M&A Rush
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks.
- Industry Trends
Germany Now Represents 62% of Canadian Cannabis Flower Exports as Portugal’s Share Collapses
Canadian cannabis exports totalled CA$51.6 million in February 2026 across the three main cannabis HS codes tracked in export data, up 8.7% on the same month a year earlier.
- International Regulation
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow nearly tenfold in just three years, according to new official data.
- Cultivation
Overwhelming Majority (80%) of Canadian Cannabis Now Sourced from Legal Distributors in Major Turnaround
Nearly 80% of Canadian’s now source their cannabis solely from the legal market, marking a stark shift away from the illicit market seven years after legalisation.
- Medical
Could Australia Be the Next Country to Impose Tariffs on Canadian Cannabis?
Australia’s medical cannabis market is thriving, with revenues expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028, according to Prohibition Partners’ Global Cannabis Report: 5th Edition.
- Uncategorized
MediPharm On the Brink: Shareholder Revolt Reaches Boiling Point as Board Fight for Survival at Canandian Cannabis Giant
A bitter boardroom battle has erupted at MediPharm Labs, one of Canada’s leading pharmaceutical cannabis companies, as investor Apollo Capital moves to unseat the entire board amid allegations of financial misconduct, mismanagement, and self-enrichment.
- Medical
Tariff Crisis: Israel’s Cannabis Industry Torn in Two as 165% Import Tax Hangs in the Balance
Israel’s cannabis industry is engaged in a heated and divisive showdown as a proposed 165% tax on Canadian cannabis imports, on which a large portion of the industry and many patients rely, hangs in the balance.
